Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01007123
Other study ID # A3309-002
Secondary ID
Status Completed
Phase Phase 2
First received November 2, 2009
Last updated January 19, 2012
Start date November 2009
Est. completion date October 2010

Study information

Verified date October 2010
Source Albireo
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with chronic idiopathic constipation.


Recruitment information / eligibility

Status Completed
Enrollment 190
Est. completion date October 2010
Est. primary completion date October 2010
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- Patient meets protocol specified criteria for constipation

- Patient has successfully completed study requirements with no clinically relevant findings for physical exam, ECG, laboratory tests and colonoscopy as applicable

Exclusion Criteria:

- Medical history or medical condition that would not make the patient a good candidate for the study or limit the patient´s ability to complete the study

- Patient reports loose stools

- Patient has IBS with pain/discomfort as predominant symptom

- Patient needs medications prohibited as specified in the protocol

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
A3309
A3309 in three different dosage levels or placebo once daily for the duration of the study

Locations

Country Name City State
United States Albireo Investigative Site Albuquerque New Mexico
United States Albireo Investigative Site Anaheim California
United States Albireo Investigative Site Anderson South Carolina
United States Albireo Investigative Site Annapolis Maryland
United States Albireo Investigative Site Baltimore Maryland
United States Albireo Investigative Site Boynton Beach Florida
United States Albireo Investigative Site Chandler Arizona
United States Albireo Investigative Site Charlotte North Carolina
United States Albireo Investigative Site Chattanooga Tennessee
United States Albireo Investigative Site Chesterfield Michigan
United States Albireo Investigative Site Cincinnati Ohio
United States Albireo Investigative Site Cincinnati Ohio
United States Albireo Investigative Site Clive Iowa
United States Albireo Investigative Site Colorado Springs Colorado
United States Albireo Investigative Site Davenport Iowa
United States Albireo Investigative Site Dayton Ohio
United States Albireo Investigative Site El Paso Texas
United States Albireo Investigative Site Encinitas California
United States Albireo Investigative Site Great Neck New York
United States Albireo Investigative Site Greensboro North Carolina
United States Albireo Investigative Site Harrisburg North Carolina
United States Albireo Investigative Site Henderson Nevada
United States Albireo Investigative Site Hollywood Maryland
United States Albireo Investigative Site Huntsville Alabama
United States Albireo Investigative Site Inverness Florida
United States Albireo Investigative Site Kingsport Tennessee
United States Albireo Investigative Site La Crosse Wisconsin
United States Albireo Investigative Site Levittown Pennsylvania
United States Albireo Investigative Site Longview Texas
United States Albireo Investigative Site Lynchburg Virginia
United States Albireo Investigative Site Marlton New Jersey
United States Albireo Investigative Site Mission Kansas
United States Albireo Investigative Site Monroe Louisiana
United States Albireo Investigative Site Ogden Utah
United States Albireo Investigative Site Oklahoma City Oklahoma
United States Albireo Investigative Site Overland Park Kansas
United States Albireo Investigative Site Peoria Illinois
United States Albireo Investigative Site Phoenix Arizona
United States Albireo Investigative Site Salt Lake City Utah
United States Albireo Investigative Site San Antonio Texas
United States Albireo Investigative Site San Diego California
United States Albireo Investigative Site Shreveport Louisiana
United States Albireo Investigative Site Statesville North Carolina
United States Albireo Investigative Site Winston-Salem North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Albireo

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in frequency of spontaneous bowel movements Weekly No
Secondary Responder analyses for complete spontaneous bowel movements weekly and for duration of study No
Secondary Time to first bowel movement First week No
See also
  Status Clinical Trial Phase
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Recruiting NCT06292949 - Clinical Study of Resistant Starch in Improving Constipation N/A
Recruiting NCT04132661 - MRI Assessment of Mode of Action of Bisacodyl, Single Dose Phase 4
Terminated NCT02839889 - Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation) Phase 4
Completed NCT02726295 - The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study Phase 4
Recruiting NCT02255747 - Anal Dilatation for Infants and Children With Constipation N/A
Completed NCT02246647 - Biomarkers for Intestinal Permeability in Patients With Constipation
Completed NCT01566409 - Maintenance Treatment for Children With Constipation N/A
Completed NCT02863848 - Effect of Inulin-type Fructans on Constipated Children. N/A
Completed NCT01695915 - Diurnal Variation in Rectal Diameter N/A
Completed NCT01710579 - Normal Values in Ano-rectal 3D High Resolution Manometry N/A
Completed NCT02658201 - Ultrafast MRI Imaging to Exclude Constipation N/A
Completed NCT01474499 - A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation Phase 3
Completed NCT01411501 - Efficacy and Safety of Acupuncture for Functional Constipation Phase 3
Completed NCT01438567 - A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy Phase 3
Completed NCT01170039 - The Effectiveness of Lubiprostone in Constipated Diabetics Phase 4
Completed NCT00931853 - Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC). Phase 3
Active, not recruiting NCT02442115 - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Completed NCT00994851 - Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment. Phase 3
Terminated NCT01003249 - Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen Phase 4